Monthly Archives: July 2026

MHRA Drug Safety Update: Domperidone: new contraindication in patients with phaeochromocytoma due to the risk of severe hypertension. The product information has been updated for all domperidone products, to include a contraindication for patients with confirmed or suspected phaeochromocytoma (a rare tumour of the adrenal gland), due to the risk of episodes of severe hypertension. [...]

The post MHRA Drug Safety Update: Domperidone new contraindication appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (21/07/2026) confirmed the following list of price concessions for July 2026: Drug Pack size Price concession Apixaban 5mg tablets 56 £1.39 Aqueous cream 500 £6.59 Aripiprazole 10mg tablets 28 £2.75 Ascorbic acid 500mg tablets 28 £45.62 Aspirin 75mg dispersible tablets 28 £2.95 Aspirin 75mg dispersible [...]

The post July 2026 Price Concessions 3rd Update appeared first on Community Pharmacy England.

Yvette Cooper has been appointed Secretary of State for Health and Social Care. The Rt Hon Yvette Cooper (MP for Pontefract, Castleford and Knottingley) is an experienced Cabinet Minister, previously serving as Foreign Secretary, Home Secretary, Chief Secretary to the Treasury and Work and Pensions Secretary. Her first ministerial role was as Public Health Minister. [...]

The post Health Ministerial Team changes appeared first on Community Pharmacy England.

Pharmacy owners have one week left to claim an Aspiration payment for the Pharmacy Quality Scheme (PQS) 2026/27 as the window for claiming this payment closes at 11.59pm on Tuesday 28th July 2026. The Aspiration payment is optional; if pharmacy owners do not want to claim it, it will not impact on the pharmacy owner’s [...]

The post PQS: One week left to claim the Aspiration payment appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Xaggitin XL Prolonged-release Tablets (Macarthys Laboratories Ltd T/A Martindale Pharma) Drug alert number: EL(26)A/35 Date issued: 20 July 2026 Macarthys Laboratories Ltd T/A Martindale Pharma has notified the MHRA of a manufacturing issue impacting several batches of Xaggitin XL Prolonged-release Tablets, due to the occurrence of incorrect tablet counts in [...]

The post MHRA Class 4 Medicines Defect Notification: Xaggitin XL Prolonged-release Tablets (Martindale Pharma) appeared first on Community Pharmacy England.